VEU.AX - Vanguard All-World ex-US Shares Index ETF

ASX - ASX Delayed price. Currency in AUD
68.46
-0.50 (-0.73%)
At close: 4:10PM AEDT
Stock chart is not supported by your current browser
Previous close68.96
Open68.56
Bid68.45 x 0
Ask69.50 x 0
Day's range68.06 - 68.56
52-week range67.38 - 73.82
Volume25,698
Avg. volume24,606
Net assets1.34B
NAV71.90
PE ratio (TTM)N/A
Yield2.79%
YTD return5.83%
Beta (3Y Monthly)0.79
Expense ratio (net)0.00%
Inception date2009-05-08
  • What US Investors Need to Know about Emerging Market Risks
    Market Realistlast month

    What US Investors Need to Know about Emerging Market Risks

    Among the emerging market (VEU) currencies, the Argentinian peso, Turkish (TUR) lira, Indonesia rupiah, and Indian rupee are declining to all-time lows. The US dollar is also strengthening against all major currencies, including those of emerging markets. As the US dollar strengthens and interest rates rise, the cost of servicing US debt for other countries goes up.

  • How GSK’s Consumer Healthcare Segment Fared in Q1 2018
    Market Realist5 months ago

    How GSK’s Consumer Healthcare Segment Fared in Q1 2018

    GlaxoSmithKline’s (GSK) Consumer Healthcare segment includes various products for oral health, wellness, nutrition, and skin health. The Consumer Healthcare segment reported a 3% fall in its YoY (year-over-year) revenue to ~2.0 billion pounds in Q1 2018 compared to Q1 2017.

  • We're sorry, but this is all we were able to find on this topic.